Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897910978> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2897910978 endingPage "e284" @default.
- W2897910978 startingPage "e284" @default.
- W2897910978 abstract "Patients with Stage IVA nasopharyngeal carcinoma (NPC) have the worst prognosis among locoregional disease. The purpose of this retrospective study was to evaluate the efficacy of gemcitabine based regimen versus paclitaxel based regimen when used as induction chemotherapy for stage IVA NPC. A retrospective analysis of 145 patients of newly diagnosed stage IVA nasopharyngeal carcinoma (8th AJCC stage) between June, 2010 and December, 2012, was performed. All were treated with 2-3 cycles of induction chemotherapy followed by platinum-based concurrent chemoradiotherapy. The induction chemotherapy regimen was TP (paclitaxel + platinum) or GP (gemcitabine + platinum). The median follow-up was 57 months. Ninety-two patients (63.4%) underwent TP induction chemotherapy and 53 patients (36.6%) received GP induction chemotherapy. The clinical parameters were balanced between the two groups. Univariate and multivariate analysis showed that the regiment of induction chemotherapy was the main prognostic factor affecting overall survival (OS). The 5-year OS of GP group was higher than that of TP group (94.2% vs 75.4%, P = 0.007). The distant metastasis free survival of GP group was slightly higher than that of TP group (83.2% VS. 74.7%), however, the difference was not statistically significant (P = 0.425). The local recurrence free survival was similar between the two treatment groups (89.7% vs.89.5, P = 0.636). GP regimen served as a first-line induction chemotherapy may improve the overall survival of NPC patients with stage IVA disease. It is worthy to be validated by further phase III clinical trials." @default.
- W2897910978 created "2018-10-26" @default.
- W2897910978 creator A5024468864 @default.
- W2897910978 creator A5040802960 @default.
- W2897910978 creator A5044071076 @default.
- W2897910978 creator A5044512741 @default.
- W2897910978 creator A5046688331 @default.
- W2897910978 creator A5059392900 @default.
- W2897910978 creator A5069224733 @default.
- W2897910978 date "2018-11-01" @default.
- W2897910978 modified "2023-09-26" @default.
- W2897910978 title "Gemcitabine Based Induction Chemotherapy may Improve the Survival of Stage IVA Nasopharyngeal Carcinoma" @default.
- W2897910978 doi "https://doi.org/10.1016/j.ijrobp.2018.07.907" @default.
- W2897910978 hasPublicationYear "2018" @default.
- W2897910978 type Work @default.
- W2897910978 sameAs 2897910978 @default.
- W2897910978 citedByCount "0" @default.
- W2897910978 crossrefType "journal-article" @default.
- W2897910978 hasAuthorship W2897910978A5024468864 @default.
- W2897910978 hasAuthorship W2897910978A5040802960 @default.
- W2897910978 hasAuthorship W2897910978A5044071076 @default.
- W2897910978 hasAuthorship W2897910978A5044512741 @default.
- W2897910978 hasAuthorship W2897910978A5046688331 @default.
- W2897910978 hasAuthorship W2897910978A5059392900 @default.
- W2897910978 hasAuthorship W2897910978A5069224733 @default.
- W2897910978 hasConcept C126322002 @default.
- W2897910978 hasConcept C141071460 @default.
- W2897910978 hasConcept C143998085 @default.
- W2897910978 hasConcept C144301174 @default.
- W2897910978 hasConcept C146357865 @default.
- W2897910978 hasConcept C151730666 @default.
- W2897910978 hasConcept C2776611710 @default.
- W2897910978 hasConcept C2776694085 @default.
- W2897910978 hasConcept C2777292972 @default.
- W2897910978 hasConcept C2778997737 @default.
- W2897910978 hasConcept C2780258809 @default.
- W2897910978 hasConcept C2781413609 @default.
- W2897910978 hasConcept C38180746 @default.
- W2897910978 hasConcept C509974204 @default.
- W2897910978 hasConcept C71924100 @default.
- W2897910978 hasConcept C86803240 @default.
- W2897910978 hasConceptScore W2897910978C126322002 @default.
- W2897910978 hasConceptScore W2897910978C141071460 @default.
- W2897910978 hasConceptScore W2897910978C143998085 @default.
- W2897910978 hasConceptScore W2897910978C144301174 @default.
- W2897910978 hasConceptScore W2897910978C146357865 @default.
- W2897910978 hasConceptScore W2897910978C151730666 @default.
- W2897910978 hasConceptScore W2897910978C2776611710 @default.
- W2897910978 hasConceptScore W2897910978C2776694085 @default.
- W2897910978 hasConceptScore W2897910978C2777292972 @default.
- W2897910978 hasConceptScore W2897910978C2778997737 @default.
- W2897910978 hasConceptScore W2897910978C2780258809 @default.
- W2897910978 hasConceptScore W2897910978C2781413609 @default.
- W2897910978 hasConceptScore W2897910978C38180746 @default.
- W2897910978 hasConceptScore W2897910978C509974204 @default.
- W2897910978 hasConceptScore W2897910978C71924100 @default.
- W2897910978 hasConceptScore W2897910978C86803240 @default.
- W2897910978 hasIssue "3" @default.
- W2897910978 hasLocation W28979109781 @default.
- W2897910978 hasOpenAccess W2897910978 @default.
- W2897910978 hasPrimaryLocation W28979109781 @default.
- W2897910978 hasRelatedWork W2024219304 @default.
- W2897910978 hasRelatedWork W2085978374 @default.
- W2897910978 hasRelatedWork W2136126967 @default.
- W2897910978 hasRelatedWork W2390264150 @default.
- W2897910978 hasRelatedWork W2392262560 @default.
- W2897910978 hasRelatedWork W2414824373 @default.
- W2897910978 hasRelatedWork W2464098867 @default.
- W2897910978 hasRelatedWork W2953569012 @default.
- W2897910978 hasRelatedWork W3030223433 @default.
- W2897910978 hasRelatedWork W3088147634 @default.
- W2897910978 hasVolume "102" @default.
- W2897910978 isParatext "false" @default.
- W2897910978 isRetracted "false" @default.
- W2897910978 magId "2897910978" @default.
- W2897910978 workType "article" @default.